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Since the introduction of the hypothesis that abnormal
transmethylation of biogenic amines may be associated with
mental illness, transmethylation processes have been she .71
to be important in the production of biologically active
amine derivatives. Laduron has shown that dopamine can be
N-methylated with an enzyme from rat brain that requires
5-methyltetrahydrofolic acid ( 5MTHF ) as a methyl donor. This
study shows that the methylation reaction v/hich produces epinine
from dopamine is greatest with supernatant from homogenized
caudate lobe as compared to the cerebellum, hippocampus,
cortex, and raphe nucleus: the brains of male rats were
dissected and homogenized, the supernatant was assayed for
5MTHF dependent dopamine-N-methyl transferase activity by
incubation with dopamine and C -5MTH?, separation of the
the catecholamines with alumina columns, counting radioactivity
with a scintillation counter, and identification of epinine
with Amberlite column chromatography. The medial forebrain
bundle (DA containing neurons) and the raphe nucleus ( 5HT
containing neurons) were lesioned. There was no significant
change in enzyme activity in the caudate after these lesions.




In 1884 J.L.W, Thudichum wrote:
Many forms of insanity are unquestionably the
external manifestations of the effects upon the
brain-substance of poisons fermented within the
body, just as the mental aberrations accompanying
chronic alcoholic intoxication are the accumulated
effects of a relatively simple poison fermented
outside the body. These poisons we shall, I have
no doubt, be able to isolate after we know the normal
chemistry to its uttermost detail. And then will
come in their yturn the crowning discoveries to
which all our efforts must ultimately be directed,
namely, the discoveries of the antidotes to the
poisons, and to the fermenting causes and processes
which produce them. (1)
This hypothesis that mental illness results from abnormal
metabolism in the brain received renewed interest in 1952
when Osmond and omythies (2) discussed that it had been known
for a long time that the symptoms of mescaline intoxication
and schizophrenia were very similar and, in addition, that
mescaline's chemical structure was close to that of adrenaline.
A biochemical note by Harley-Mason published in their paper
It is extremely probable that the final stage in the
biogenesis of adrenealine is a transmethylation of
noradrenaline, the methyl group arising from methionine
or choline. It is just possible that a pathological
disordering of its transmethylation mechanism might
lead to methylation of one or both of its phenolic
hydroxyl groups instead of its amino group,. . Me tr.yl-
ation of phenolic hydroxyl groups in the animal boay
is of rare occurrence, but a significant ca^e has
been reported recently. ... It is particularly inter
esting to note that out of a series of phenylethylamine
derivatives tested by Noteboom, 3i4-dimethoxyy:i.enyl-
ethylamine was the most potent in producing catatonia
in animals. . . .
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Thus began the work that has shown transmethylation
processes to be important in the production of biologically
active amine compounds. Most of this research has been con
cerned with transmethylation enzymes which use S-adenosyl-
methionine (SAM) as a carbon donor. Laduron (3) has recently
reported an enzyme in rat brain which can convert dopamine
(DA) to N-methyl dopamine (epinine) using 5-methyl tetra-
hydrofolic acid (5MTHF) as the carbon donor. This thesis is:
1. a study of the regional distribution of the
5MTHF dependent dopamine-I! -methyl transferase
in rat brain.
2. a study of the effect on this enzyme of the
destruction of DA and serotonin (5HT) containing
cells in the brain.
3. a demonstration of the presence of the enzyme in
post mortem human caudate tissue.
Transmethylation Enzymes
After the proposal of the Harley-Mason hypothesis it was
noted (4) that LSD and 5HT showed a pharmacological antagonism,
and it was suggested that serotonin might be N- and 0- methyl
ated to form various psychotomimetic derivatives. In 1957
Axelrod (5) reported that his search for an enzyme that would
inactivate noradrenaline and adrenaline had led to the discovery
of the 0-methylation of adrenaline to metanephrine. The
enzyme, catechol-O-methyl transferase (COMT), was purified (6)
+ 2
and found to require SAM and Mg. It was non-specific, being
capable of 0-methylating all catechols.
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The discovery of COMT was followed by the discovery of
a whole series of methyl transferase enzymes which are listed
in Table I (7). Some of these enzymes are capable of making
psychotomimetic compounds as proposed by Harley-Mason.
Axelrod (8,9) found a non-specific N-methyl transferase
highly localized to rabbit lung that used SAM as a carbon
donor and was able to N-methylate 5HT to the psychotomimetic
products bufotenine and N-N -dimethyl tryptamine (DMT) . This
enzyme also N-methylates phenylethanolamine derivatives such
as mescaline and dopamine. This enzyme was found almost
entirely in rabbit lung, an unlikely place for the action of
psychotomimetic drugs. Phenylethanolamine N-methyl transferase
(PNMT) was found in mammalian adrenal medulla and was capable
of transferring a methyl group to a variety of phenylethanol
amine derivatives (10). Mandell and Morgan (11) found an
enzyme in chick, sheep, and human brain that N-dimethylated
tryptamine to form DMT; and Saavedra and Axelrod (12) showed
that rat brain was capable of forming DMT in vivo.
PNMT participates in the major accepted pathway for the
biosynthesis of the catecholamines shown in Figure 1 (13).
An alternate pathway to adrenaline which bypasses noradrenaline
was first proposed by Halle in 1906 (13). After Da is N-
methylated to epinine it is B-hydroxylated to adrenaline.
It was confirmed that dopamine-B-hydroxylase could do this
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TYROSINE TYRAMINE OCTOPAV.INE SYNEPHRINE
Biosyntliesis of catecholamines. DBII dorarninc-S-hydroxylasc; NMT nonspecific mcthyltransfcrase; AAD aromatic acid
decarboxylase; PNMT phenylethanolamine- N-mctliy! transferase; CFE catecholamine- forming enzyme.
Figure 1. The Biosyntherjis oi the Catecholamines (13)
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role of epinine in the CNS except that it may be a precursor
of adrenaline. As DA, noradrenaline, and adrenaline do not
cross the blood brain barrier it is unlikely that epinine
does. Exogenously administered epinine acts as an effective
sympathomimetic in the periphery but it has little if any
central action (33).
Transmethylation Processes and Psychosis
Attempts have been made to correlate these biochemical
findings with clinical situations. Much of this has been
reviewed by Kety (15) and Boulton (16). Narasimhachari,
Plaut, and Himwich (17) looked in human serum for an enzyme
capable of N-methylating serotonin. In a small series, they
found no activity in the serum of their normal controls, but
of seven samples from acute schizophrenics, six were positive
for either bufotenin or 5-methoxy-N-N-dimethyltryptamine.
Wyatt et al (18) have found an enzyme capable of forming DMT
in red blood cells, plasma and platelets. The enzyme activity
in the red blood cells and plasma was similar in psychiatric
patients and normal subjects but the enzyme activity in the
platelets was higher in psychotic subjects than in nonpsychotic
subjects. N-methyl transferase activity of the platelets
could be increased by dialysis, implying the presence of
an inhibitor.
-7-
Hoffer (19) treated schizophrenic patients with the methyl
acceptors niacin and nicotinamide in an attempt to inhibit
the abnormal methylation that might be occurring. Their
partial success led to a controversial chemotherapy for
schizophrenia (20). Poll in, Cardon, and Kety (21) tested
the theory one step further by studying the effects of feed
ing large doses of methionine and tryptophan to schizophrenics.
The amino acids caused behavioral symptoms, some of which seemed
to be exacerbations of the psychoses. The findings were
confirmed by several independent groups, including one
using betaine as a methyl donor (22). Feeding methionine to
nonpsychotic patients also caused behavioral changes (23).
It is not known, however, whether the resulting symptoms are
truly an intensification of the pre-existing psychosis, or a
toxic psychosis, or if an abnormal methylation is even
involved.
Friedhoff and Winkle (24) reported that they had found
3,4-dimethoxyphenylethylamine (DMFEA), v/hich became known as
the pink spot, in the urine of schizophrenics. This report
began one of the most controversial issues in the biochemistry
of schizophrenia. The pink spot is critically reviewed by
Siegel (25), who found it related to chlorpromazine ingestion.
Stabenau (26) observed that DMPEA can be produced in the urine
of both normal subjects and schizophrenics provided they drink
tea. Narasimhachari et al (27), using a more selective and
-8-
specific test for DMPEA, were unable to find it in the urine
of their psychiatric patients and controls whether or not they
were tea drinkers.
In addition to these major issues there are many other
studies attempting to relate methylation processes to schi
zophrenia. Abnormal methionine metabolism, for example, has
been reported in schizophrenic patients (28), and schizophrenia
has been found in a number of families with homocystinuria (29).
5MTHF as a Methyl Donor
Laduron discovered the 5MTHF dependent methylating
-
enzyme while looking in rat brain for an extra -granular N-
methyl transferase that would obviate the seemingly uneconomical
translocations of noradrenaline and adrenaline from the granules
to the extra -granular space and back again (30i31). Unlike
the extra -granular dopamine-N -methyl transferase he found
(30) in the adrenal medulla, which uses SAM as a methyl donor,
the enzyme in rat brain was able to use only 5>:<"THF.
5MTHF has since been observed (34) to participate with
greater activity than SAM in the N- and 0- methylation of
phenylethylamines and indoleamines by extracts of mammalian
and avian tissues (see Table II). Among the in vitro
products formed by the 5"'-THF dependent enzyme are the psycho
tomimetic agents bufotenin and 5-methoxy-N-N-dimethyltryptamine.
-9-
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S T S/T s T S/T S T
Rabbit lunc 32.0 24.0 J.33 8.0 4.0 2.0 4.0 6.0
Rabbit brain 0 005 0 2.6 1.4 1.9 0 0 04
Rabbit In cr 0 0.2 0 2.1 1.2 1.7 0 0.0a
Kit brum 0 0.4 0 3.0 1.3 2.3 0 0.31
Ratliu-r 0 1.2 0 4.3 1.4 3.1 0 0.90
R.i! It:nn 0 0.35 0 40 1.3 3.1 0 0.27
Rat lie.irl 0 0.4 0 8.0 3.0 2.7 0 0.14
Clu.H Ir.iin. 0 1.0 0 6.0 4.0 1.5 0 0.25
Chi.'Uieait 0 2.0 0 :co 11.0 2.3 0 0 18
74
Table II. Cor.'carisor of SAL", and 5--TH? dependent r: ethyl
transferase encyr.e activities '34)
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These findings introduce the question of the role of folate
coenzymes in neural metabolism and psychiatric illness.
Folic Acid Metabolism
While most dietary folates are pteroylpolyglutamates
(Figure 2), the predominant form of folate in the serum is
5MTHF, for during absorption hydrolysis, reduction, and methyl
ation occur (35). In addition to 5MTHF there are five other
folate coenzymes which are one-carbon derivatives at either
the N^ or N position or both as shown in Table III (36).
Little is known about the utilization of folate coenzymes in
neural tissue, but it is known that the concentration of 5MTHF
in the cerebrospinal fluid (CSF) is 3-4 times the concentration
of 5KTHF in the serum (37) i that there is a selective conser
vation of 5MTHF in the CNS (38) as opposed to a selective
exclusion of vitamin B,2 (36), that 5^THF is taken up prefer
entially in CSF while other folate congeners are converted to
5MTHF before uptake (39). and that there is an association of
disturbances in folic acid levels and neuropsychiatry
disorders (43-66) .
Folate coenzymes are intricately involved with vitamin
B,? metabolism and take part in methyl group transfer reactions
including:
1. the synthesis of purines (10-formyl THF and 5,10-
methenyl THF)
2. the synthesis of the pyrimidine thymidylate
(5,10-rnethylene THF)
3. the interconversion of serine and glycine (THF,
5,10-methylene THF)
-11-
4. the catabolism of histidine to glutamic
acid (THF)
5. the methylation of homocysteine to methionine
(5MTHF) (36)
Figure 3 summarizes these reactions. In addition, reduced
pteridine proups are required as cofactors in the metabolism
of phenylalanine to tyrosine, and tyrosine to dopa, the first
steps in the biosynthesis of dopamine, noradrenaline, and
adrenaline (13).
The folate coenzymes are all interrelated as shown in
Figure 3 (42), THF is produced as the coenzymes donate carbon
groups in the various reactions and by the reduction of dihy-
drofolate by the enzyme dihydrofolate reductase, which is
strongly inhibited by the chemotherapeutic drug methotrexate (40) .
The major pathways for the methylation of THF involve the
reactions 3 and 4 above and direct formylation using THF
formylase.
The major reaction in human metabolism in which 5^THF is
known to act as a coenzyme is the methylation of homocysteine
to methionine (24). There is one theory, in fact, that postulates
that 51.1THF can be converted to other folate congeners only
via this reaction (see methyl trap hypothesis below). This
reaction is also the only known reaction in human metabolism
which involves both folate and vitamin B.p and thus is
important in the etiology of megaloblastic anemias and neuro
psychiatry disorders associated with B.,- and folate deficiencies.
-12-
Table III. Derivatives of Tetrahydroiolic acid (36)
Derivative













Figure 2. Structure of Folic Acid and Tetrahydrofolic acid
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Figure 3. Metabolism of Tetrahydroiolic Acid (42)
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Homocysteine is methylated to methionine via two
possible systems. One, found in bacteria and not known in
humans, is independent of vitamin B,2. The other, found in
bacteria and tiiamans, is dependent on the presence of vitamin
B12 as shown ^n Figure 4 (40, 41). The cobalamin dependent
reaction was the first and most extensively studied reaction.
2 4.
The cofactors ATP, Mg , and FADH2 or its equivalent are
necessary :for the reaction. The reaction
5MTHF + homocysteine > THF -f methionine
is catalyzed by homocysteine methyl transferase. The apoenzyme
is converted to the holoenzyme when it combines with the
cobalamin prosthetic group that receives the methyl group
from 5KTHF and gives it to homocysteine. The methyl transfer
is stimulated by SAM (41).
The methyl trap hypothesis is the most accepted theory
for the etiology of megaloblastic anemia (35). The theory
holds that the lack of vitamin B,9 prevents 5<V'THF from
participating in homocysteine methylation. Folate accumulates
as 5MTHF, reducing the amounts of folate coenzymes needed in
other reactions, 7/hen these fall below a threshold, nucleic
acid formation fails. This theory is not accepted by all, but
at the present there is no better explanation of the role
of folate and vitamin B,p in. megaloblastic anemias (40).
The non-cobalamin pathway in bacteria and lower animals
2+
uses only 5^THFdiglutamate and Mg , and is not known to occur
in humans. It is interesting to note the close relationship
-15-









Figure 4. Cobalamin and r;on-cobalamin dependent pathways for
Methionine ^Biosynthesis (40)
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between 5MTHF and methionine, particularly in light of the
methionine feeding experiments mentioned before. It has been
found that methionine feeding in cobalamin-def icient animals
and humans greatly decreases fromiminoglutamate excretion in
addition to decreasing both the amount of 5MTHF relative to
other folates in liver and the level of total folates in
liver (40).
Folates and Neuropsychiatric Disorders
Laduron (3) suggests that since 5KTHF has been found to
take part in the metabolism of biogenic amines, it is possible
that an excess of folate coenzymes could give rise to an
increased or unusual formation of N -methylated amines. Folic
acid deficiencies and toxicities have been implicated in
neuropsychiatric disorders, mainly in patients receiving the
anti-convulsant drugs diphenylhydantoin, phenobarbital, and
primidone. Reynolds (43,44) and Rothfeld (45) have reviewed
the literature.
Three studies (46-48) found significantly lower serum
folate levels in epileptic patients v/ith mental illness than
in epileptic patients with normal mental states. In two of
these studies (47,48) psychotic (dementia, schizophrenia-like,
depression) patients had lower serum folate levels than non
psychotic epileptics. Other studies have shown that reduced
-17-
serum folate levels are accompanied by corresponding changes
in the red cell folate levels (49) and in the CSF (50, 51),
Horvitz et al (52) take exception, finding low levels in all
his epileptic patients with no significant difference between
epileptic patients with and without neuropathy.
Treatment with folic acid has yielded conflicting results.
Reynolds (53) treated 26 chronic epileptic patients with folic
acid deficiency due to anticonvulsant drugs and found that
mental state improved in 22 with increased drive, speed of
cerebration, alertness, self-confidence, independence, and
sociability. Neubauer (54) found improvement in mental s.tate
in folate deficient epileptic children 5-8 weeks after
beginning treatment with folic acid and vitamin B ?
On the other hand, Spaans (55) in a controlled double
blind study found that after three months of folic acid therapy,
serum folate levels had risen but CSF folate levels showed no
rise. Mattson et al (5^>) treated epileptic patients in a
double blind study with folic acid for six months and found
no change in CSF folate levels, no change in seizure activity,
and no improvement in mental activity. Since it had boon sho':i
that diphenylhydantoin did not alter uptake of 5MTHF into the
CSF (38), it was postulated by Mattson et al that the anticon
vulsants interfered with conversion of folic acid to 5mTHF.
V/hen a small group was treated with folinic acid ( 5 formylTHF)
CSF levels rose rapidly.
-18-
Folate deficiencies have been implicated in non-epileptic
neurological and psychiatric patients. Reynolds, Rothfeld,
and Pincus (57) studied the neurological status of acute
general medical patients with and without serum folate deficiency,
controlling for degree of anemia and presence of alcoholism.
The folate deficient group had a significantly larger number
of organic brain syndromes and pyramidal tract changes.
Pincus, Reynolds, and Glaser (58) reported a woman whose
symptoms of subacute combined system degeneration: megaloblastic
anemia, dementia, impairment of posterior column function,
absent reflexes, and bilateral Babinski signs, all disappeared
with folic acid therapy. Strachan and Henderson (59)
reported two patients with megaloblastic anemia and advanced
dementia; both markedly improved with folic acid therapy. In
a retrospective study, Carney (60) found that psychiatric
patients with organic psychosis, endogenous depression, and
schizophrenia who had been given folic acid were discharged
more quickly and in a better clinical state that those who had
not received folic acid. It has been found that inborn errors
in folate metabolism can cause mental retardation (6l).
In addition to these studies on the effect of folic acid
deficiency, Hunter et al (62) report the toxicity of folic
acid. 15 mg/day of folic acid was given to a group of 14
healthy volunteers. The study had to be stopped after one
month because most subjects had GI or nervous symptoms or
both. This study v/as not controlled, however, and the
-19-
symptoms listed were varied and questionable.
Hunter (63) suggests an explanation for his findings.
Noting that pteridine cofactors are required in brain amine
metabolism, he postulates that excess folate may inhibit the
enzyme dihydrofolate reductase and thereby decrease the amount
of biologically active THF. As supporting evidence he notes
that he found CSF homovanillic acid levels were lowered by
folic acid ingestion. This does not, however, say anything
about THF levels or enzyme inhibition, nor is any mechanism
for HVA reduction proposed.
Hellstrom (64) followed this report with a controlled
double blind study. Psychic reactions were measured with a
questionnaire. No differences were observed between controls
and subjects. Hellstrom notes, however, that the serum folate
levels in her patients were much lower than in Hunter's study.
Reynolds (65) has reviewed the evidence that increases
in folate levels may cause an increase in seizure disorders.
In one study he found an exacerbation of seizures in 50% of
his patients, the longer the follow up the more the deterior
ation in seizure control. Mattson et al (56) found six
months therapy v/ith folic acid had no effect on seizure frequency
or severity. In support of a theory that focal epileptic
discharges may result from the accumulation of folate at the
site of the focus as a result of local damage to the blood
brain barrier, Mayersdorf et al (66) have found folate
-20-
concentrations in the region of chronic cobalt epileptic
foci to be several times higher than in other areas of cortex.
The evidence implies that folic acid plays an important
and complex role in neural functioning. Folate levels in serum,
RBC, and CSF are significantly low in various forms of mental
illness, especially psychoses, but not all epileptic patients
with mental illness have low folate levels and not all epilep
tic patients with low folate levels have mental illness.
CSF levels correspond with serum levels except that treatment
with folates may not affect CSF folate levels. It is difficult
then, to account for the Improvement in mental status seen in
the various studies.
Dopamine and Serotonin Pathways in the Brain
The new methyl transferase and its interactions with
5MTHF may be important in elucidating the role of folic
acid in the nervous system. The study of the regional
distribution of the enzyme in the brain with special attention
to its relationship to dopamine and serotonin pathways seemed
especially interesting for three reasons; the role of epinine
in the biosynthesis of catecholamines, the evidence that
dopaminergic neurons in the corpus striatum may be involved
in schizophrenia (67), and the ability of the enzyme to
form psychotomimetic derivatives of serotonin.
-21-
The monoamine pathways in the central nervous system
have been the subject of numerous studies, particularly by
Dahlstrom, Fuxe, and Ungerstedt. (68-74) who used fluorescence
histochemical techniques. There are three major DA path
ways as mapped by Ungerstedt (74). The nigro-striatal path
arises in the zona compacta of the substantia nigra, ascends
in the lateral hypothalamus, enters the crus cerebri in the
mid-hypo thalamus, intermingles with the myelinated bundles
in the capsa interna, fans out in the globus pallidus, and
enters the caudate. Approximately 12$ of the nerve terminals
in the caudate are dopaminergic (75). The meso-limbic DA
system ascends with the axons of the nigro-striatal DA system,
but takes a more medial route to the nucleus accumbens,
nucleus interstitialis striae terminalis, and the olfactory
tubercle. The tub ero -infundibular DA system arises in the
arcuate nucleus in the hypothalamus and spreadsto the median
eminence, hypothalamus, and perhaps higher brain areas. The
5HT cell bodies arise in the dorsal raphe nucleus in the
midbrain and ascend to the forebrain innervating particularly
the hippocampus and cortex. A small (lc/o) amount of the
cells in the forebrain contain serotonin (76).
These findings have been confirmed in many laboratories
(77-82). Heller and Moore (77) showed that there is a large
decrease in brain serotonin after destruction of the raphe
nuclei. Other laboratories have found decreases in DA v/hen
the medial forebrain bundle or the substantia nigra is
lesioned (78,79,81), The effects of electrical stimulation
-22-
DOPAMINE
Figure 5. Sagittal projection of Dopamine pathways in brain. (74)
-23-
of the substantia nigra on the caudate have been correlated
with the effects of iontophoretic DA on caudate neuron
firing rates (80) .
The monoamine pathways correlate v/ith the regional
distribution of monoamines in the brain (83). It is
significant that DA levels are highest in the corpus striatum
(see Table IV) .
-24-
Table IV. Regional Distribution of Monoamines in Brain
adapted from Vaizelli and Garattini (83)
Brain area 5HT u.*A NA ug/g DA usr/g




Corpus stria.turn 0.30 0.71 5.25
Cerebellum n.m. 0.14 n.m.





Preparation of C -5MTHF
50 fxCi of Ba:C -5MTHF (Specific Activity 57 uCi/umol,
Amersham) is taken up in 1.5 ml 0.1 M sodium bicarbonate.
2.5 ml sodium ascorbate (5 mg/ml, pH adjusted to 6 with NaOH)
is added and follov/ed by 1.0 ml disodium phosphate. The solution
is centrifuged at 1000 Xg and the supernatant is divided
into vials.
Assay of N-methyl transferase activity
The brains of male rats (Charles River, 200-300 g) were
homogenized in four volumes of 0.1 M Tris buffer at pH 7.9.
The homogenate was centrifuged at 16,000
x
g for 15 min.
The N-methyl transferase activity of the supernatant pre
paration v/as then assayed in an incubation mixture containing
0.1 M Tris buffer at pH 7.9; 20 umol DA substrate; 0.5uCi
C^" -5MTHF; 5 umol SDTA ; 8 umol dithiothreotol ; and a sample
of supernatant in a final total volume of 1 ml. Boiled
supernatant was used as a blank. The mixture was incubated
for 1 hour at 37 C. Each reaction was stopped with the
addition of 3 ml of 10$ trichloroacetic acid; and the mixture
was centrifuged at 36, 000 X g for 15 min. 50 ug carrier
epinine, 0.4 ml 10$ EDTA, and 0.2 ml 1 M Tris buffer at pH
-26-
8.4 were added to each sample; the pH was adjusted to
8.4 with NaOH; and the samples were poured over columns of
aluminum oxide (85). After v/ashings with 30 ml H20 , the
amines were eluted with 2 ml 1 N HC1 followed by 2 ml H20 .
An aliquot of the eluate v/as counted v/ith 10 ml of scintilla
tion solution in a Packard liquid scintillation counter.
Chromatography
The remainder of the -eluate from three experiments
was poured over alumina columns a second time, eluted with
0.2N PCA, and subjected to ion exchange column chromatography




Protein measurements as described by Lowry et al ($70
were performed on whole rat brain and caudate, and human
caudate samples.
Enzyme Activity
DA, eolnine, folate, and supernatant concentrations
were varied to study the effects on the reaction. Time studies
were done from 15 to 150 min. The regional distribution of
the enzyme activity v/as studied by dissecting and separately
homogenizing and assaying supernatant fractions of the cortex,
-27-
the hippocampus, cerebellum, and caudate. In one
experiment, a tissue slice containing the raphe nucleus
was assayed. Enzyme activity was measured in fresh tissue
and tissue that had been frozen from one hour up to three
months.
Human Caudate Enzyme Activity
Three pieces of humand caudate, about .2 g each, were
obtained from a 56 year old woman who had died of metastatic
ovarian carcinoma. The samples were frozen (-20 C) for 48
hours, homogenized and assayed as described above. A fourth
piece was assayed after being frozen for 2 months.
Lesioning of Medial Forebrain Bundle and Raphe Nucleus
The rats were lesioned as described by Walters (81).
They were anesthetized with halothane and mounted in a
stereotaxic device. The skull v/as exposed, and a 3 mm
burr hole v/as made on the left side at 1300 u lateral ana
2790 u anterior according to Konig and Klippel (82). A
metal electrode made from a #1 insect pin, coated three times
with and then scraped mm clear of insulation at the point,
was lowered 8.3 mm from the skull surface. A 20 sec
electro thermic lesion was mad with a Grass LM4 Lesion
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Maker set at 15-20 mAmp. The wound was clipped shut and
the animals were allowed to recover from the anesthetic. Nine
days after the lesion the rats were decapitated and the
caudates were dissected out with care to keep the left (lesioned
side) and right ( unlesioned) side separate. Each caudate v/as
assayed separately for enzyme activity. The assay procedure
was the same as above, except that only 0.3 - 0.5 ml super
natant was available for the assay due to the small amount of
tissue.
The raphe lesion technique was similar except that the
coordinates used v/ere anterior 340 u, lateral 0 u, and horizontal
6.5 mm and 7.5mm (84). As the raphe lesion affects both
caudates, unlesioned rat brains were used as controls. In
this experiment, the caudates were homogenized in 10 volumes
of buffer.
Histology was performed on the lesioned brains to confirm
the location of the lesion. The tissue was placed in a 5%
gluteraldehyde solution for 48 hours. Sections were made at
50 u intervals with a microtome freezing stage, and mounted
on glass slides smeared with albumin. The sections v/ere stained
with crystal violet solution: slides were dipped successively
into staining dishes containing 95$ ethanol, distilled H20 ,
0.1$ crystal violet acetate (Fisher) for 5 min, distilled
H 0, 95$ ethanol with a few drops of acetic acid, absolute
ethanol, 50 j 50 solution of absolute ethanol rxylene, absolute
ethanol, and xylene. The slides were examined to determine
location and size of the lesion. If the extent and location
of the lesion v/ere not correct the biochemical data from the
-29-
improperly lesioned brain was not used.
Ammonium Sulfate Purification of N-methylating enzyme
In one experiment, partial purification as described
by Laduron (3) v/as attempted. Three rat brains were homo
genized in 30 ml H20, and centrifuged at l6,000Xg for
10 min. The supernatant was centrifuged at 130.000X g
for 90 min to obtain the supernatant which was partially
purified with a precipitation at a 25$ ammonium sulphate
saturation. The pellet was discarded and the supernatant
added to a solution at 60$ ammonium sulphate saturation.
The second pellet was taken up in 0.02 M phosphate buffer
at pH 6.8, dialized overnight against the same buffer, and
then centrifuged again at 20,000* g for 20 min before being
frozen for storage before assay,
Results
Whole Brain Studies
The 5MTHF dependent dopamine-N-methyl transferase was
found to be active in the rat brain. The reaction was
follov/ed by measuring the change in product as measured by
radioactivity (DPM) in the eluate from the aluminum oxide
columns. Figure 6 shows the reaction product v/hen 0.8 ml
supernatant is incubated from 15 to 150 minutes with the
reaction mixture described above. The product increased
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linearly with time up to 90 min when . it quickly leveled
off.
Figure 7 shows the results when time was held constant
at one hour and the amount of supernatant containing enzyme
was varied from 0.2 ml to 0.8 ml. The amount of product
increased linearly as more enzyme was added to the reaction
mixture.
In the experiment shown in Figure 8, the amount of DA
substrate was varied from 175 fig, to 7 mg. The reaction
rate increased rapidly as the substrate concentration
increased to about 2 mg when the enzyme must begin to become
saturated. This curve is typical of an enzyme-catalyzed
reaction which follows Michaelis-Menten kinetics. As the
radioactivity decreased at high substrate levels, it is
possible that the reaction direction was reversed. Epinine
was also tried as a substrate and found to accept a methyl
group, but chromatography was not performed to determine
the product nor was the reaction investigated further.
In Figure 9, the DA was held constant while the 5MTHF
was varied from 0.1 to.l uCi (0.018 ur/.Jl to 0.18 umol). The
reaction product increased linearly v/ith the coenzyme until
a saturation point was reached at about 0.5 uCi.
Ion exchange chromatography was perfor;, ed to identify
the reaction products. H -DA and standards of epinine and
noradrenaline were used for comparison, as Laduron (3)
reported that the epinine peak in column chromatography
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overlaps the DA peak. In these experiments, as shown in
Figure 10, the C came off just after the H-^-DA peak,
findings consistent with standard controls. No other peaks
were found in the experimental samples.
Regional Distribution
In five separate experiments, the enzyme activity
determined as DPM/mg tissue wet weight was measured for
the cortex, hippocampus, cerebellum, and caudate. The
number of trials varied from 3 "to 8, The cortex had the
lowest amount of enzyme activity/mg tissue, and the cortical
-
enzyme activity was selected as a reference value and set
at 100$. As shown in Table V, the caudate consistently had
the most enzyme activity, about twice as much as in the
cortex. In a single experiment, tissue slices containing the
raphe nucleus were homogenized, assayed, and found to have
less activity than the cortex.
Enzyme Activity
The enzyme activity in the caudal j lobe, as shown in
Table VI, was found to be 0.112 mumol pdt. formed/ mg
protein. This is about 3 times the activity found by
Laduron in whole rat brain. The enzyme activity in the
human caudate tissue was found to be 0.115 mumol pdt.
formed/mg protein. It was found that the enzyme activity
in both human and rat caudates was changed very little v/hen
the tissue was frozen up to two months before being assayed.
-32-
The ammonium sulphate precipitation increased the enzyme
concentration, but it was decided that this procedure was
unnecessary for this study. It is important to note, however,
that the enzyme v/as present in the soluble fraction after
the ultracentrifugation.
Lesion Studies
When the medial forebrain bundle was lesioned, no
significant changes in the enzyme activity in the caudate
was found. The enzyme activity in the lesioned and unlesioned
sides is presented in Table VII. In addition, Table VIII
shows the data from the caudates when the raphe nucleus
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Tafele V. $ 5MTHF Dependent-N -Methyl Transferase Activity
in Brain Areas compared to cortex (100$ i 15$)
Brain Region Mean $ SE Significance
Cortex 100 15
Caudate 202 18 p ^.005
Cerebellum 169 13 p< .02





Table VI. Enzyme Activity expressed as mumol of product
formed in one hour/mg protein
Tissue mumol /mg protein
rat caudate 0.112
human caudate 0.115





Table VII. Caudate enzyme activity after medial forebrain
bundle lesions
DPM/mg wet weight









Mean 192 35 151 ^ 32 (n.s.)
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In initial experiments we observed that it was possible
to assay the 5*V'THF dependent DA-N-methyl transferase with
out the prior ammonium sulphate precipitation procedure used
by Laduron (3). This greatly facilitated the study of the
regional distribution of the enzyme.
The major problem presented by the enzyme assay described
by Laduron was the development of a black discoloration
during the incubation. Laduron (30) mentions this discolor
ation as most likely caused by the oxidation of the DA substrate,
and notes that EDTA and sodium metabisulf ite prevent the
oxidation from taking place. In the present studies, high
concentrations of EDTA and sodium metabisulf ite did not
protect the reaction mixture from turning black. The problem
was solved only v/ith the addition of dithiothreotol, an
effective reducing agent, which prevents the formation of the
black discoloration and allows for greater enzyme activity.
The 5MTHF dependent DA-N-methyl transferase has been
shown to be most concentrated in the caudate lobe as
compared with the cortex, hippocampus, cerebellum, and raphe.
Korevaar et al (88) have found high, levels of 5MTHF in the
caudate. The finding of enzyme and associated coenzyme to be
localized in high concentration to the same areaof the brain
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argues for the signif icanceof their reactions the alternate
pathway for the biosynthesis of adrenaline via epinine and
other N- and O-methylation reations catalized by the folate
dependent enzyme.
The high levels in the corpus striatum are also inter
esting because the striatum has been implicated in the
pathophysiology of schizophrenia (67).
What then is the physiologic and, if any, behavioral
role of the folate dependent methyl transferase? The first
step to answering this question is to try to find if the
enzyme is localized to a particular kind of cell. There was,
however, no clear cut localization to either DA or 5HT
containing neurons. V/hen the medial forebrain bundle was
lesioned (producing degeneration of DA neurons distal to
the site of the lesion) there was no significant change in
the enzyme activity in the caudate. If DA were the main
substrate and if epinine were made in the cells, one would
expect a decrease in the enzyme activity when the DA axons
degenerated,
Banerjee and Snyder (34) have reported that the folate
dependent enzyme affinity is greater for serotonin than other
biogenic amines, and have suggested
that the physiologic role
for this enzyme may involve the N-
or 0- methylation of serotonin.
When the raphe was lesioned, however, there was no decrease
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in the enzyme activity in the caudate as measured by the
N-methylation of DA.
This data implies that the enzyme is not found exclusively
in the DA or 5HT axons in the caudate. DA and 5HT terminals
account for only 13$ of the neuronal terminals found in the
caudate. The enzyme may be found in the other 87$, although
this raises the problem of how the enzyme comes into contact
with a suitable substrate. As the enzyme activity was found
in the soluble fraction on ultracentrifugation it is not in
the cell granules. It may even be outside the cells. It may
be on the post-synaptic membrane and may function in the
degradation of neurotransmitters or in the excitation of the
membrane.
It is also possible that the enzyme is ubiquitous and is
not specifically important in neuronal functioning.
5MTHF dependent enzyme activity has been found (Table II) in
lung, liver, and heart as well as brain tissue. The activity
was greatest, in fact, in lung and heart. On the other hand,
SAM dependent methyl transferase activity is also found in
tissues outside the nervous system.
While enzyme, coenzyme, and substrate
levels are all
high in the caudate, this correspondence
is not found elsewhere
in the brain. 5MTHF is highest in the midbrain raphe (88)
where enzyme activity is about half
that found in the caudate.
There is a large amount of enzyme activity in the cerebellum
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whichhas minimal amounts of 5HT and DA and only small
amounts of 5MTHF. Kemp and Powell (89-93) have extensively
studied the structure of the caudate nucleus in the cat and
conclude (93 ) that the caudate and cerebellum are similar
in structure, connections, and function. They now seem to
have a peculiar biochemical similarity. The cortex,
hippocampus, and raphe have lower but significant enzyme activity.
Another approach to investigating the role of this
enzyme would be to demonstrate its activity in vivo and
to determine the action of its product. Epinine is not
known to exist in vivo except in the parotid gland of a
South American toad, Bufo marinus (10). In preliminary studies,
14
C -5MTHF was injected into the tail vein of rats with the
intention of assaying for radioactive catecholamine metabolites
14
in the brain. After the injection of 0.5 to 3 uCi of C -5MTHF
however, only background radioactivity was found in brain
homogenates up to one hour after the injection. This contradicts
the findings of Levitt (39) but the number of trials was too
14
small for this to be conclusive evidence. C -5MTHF v/as
also injected directly into the lateral vontricles using
an interventricular cannula technique described by Verster
et al (94). The ventricular injections consistently produced
massive convulsions in the rats. The seizures may have
resulted from the nonphysiologic pH (8.4), the ascorbic
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acid in the carrier, or they may have been a demonstration
of the seizure inducing property of high concentrations of
folic acid. Brain homogenates were assayed as described and
no epinine was found to be produced up to one hour after the
interventricular injections were performed.
The 5MTHF dependent DA -N-methyl transferase may be
important in the neuropsychiatric symptoms found in folate-
B.p deficiencies. It is not known whether or not B12 is
required for the methylation of dopamine as it is for
homocysteine. If B.,2 is necessary, this system may malfunction
in deficiency states. If B.p is not necessary then the
reaction is unique and may be similar to that found in
bacteria and lov/er animals.
The involvement of folate in methionine metabolism is
interesting in light of the importance of SAM in catechol
amine metabolism. Folate deficiencies may cause neuropsychia
tric symptoms because of their effect on methionine rather
than epinine or other product, and similarly abnormal methionine
levels may affect folate,
Laduron has speculated that excess 5MTHF may lead to
excess production of epinine v/hich may function as a neuro
transmitter and be involved in schizophrenia. The high
concentration of the enzyme in the caudate makes this idea
more plausible. The results in Figure 9 show that as the
concentration of 5MTHF is increased the amount of epinine
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produced increases linearly until a saturation point is
reached. Depending on physiological conditions, this
may occur in vivo. Except for deficiency states, however,
it is rare in vivo for a coenzyme to so greatly affect the
rate of a reaction.
The enzyme activity in the human caudate samples was
very close to that found in the rat caudate. The presence
of the enzyme in human brain means that there is a real
possibility that it is important in human neuronal metabolism.
Wise and Stein (95) have found decreased levels of
dopamine-B-hydroxylase in the post mortem brains of
schizophrenics as compared to the brains of normal controls.
Now that an enzyme which can N-methylate DA has been found
in human caudate, it is possible that if dopamine-B-hydroxylase
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